(Q37292740)

19 August 2017

1 reference

title

Current management of gestational trophoblastic diseases (English)

1 reference

19 August 2017

Ross S Berkowitz

1

1 reference

19 August 2017

Donald P Goldstein

series ordinal

2

1 reference

19 August 2017

language of work or name

English

0 references

publication date

12 October 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

112

1 reference

19 August 2017

issue

3

1 reference

19 August 2017

page(s)

654-662

1 reference

Risk and prognostic factors in trophoblastic neoplasia

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Risk factors for complete molar pregnancy from a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Dietary factors and risk of trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Increased frequency of complete hydatidiform mole in women with repeated abortion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Case-control study of risk factors for partial molar pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Placental site trophoblastic tumor: a 17-year experience at the New England Trophoblastic Disease Center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Clinical characteristics of placental site trophoblastic tumor (PSTT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Placental site trophoblastic tumor: outcome of five cases including fertility preserving management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Androgenetic origin of hydatidiform mole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Human lymphocyte antigen expression in hydatidiform mole: Androgenesis following fertilization by a haploid sperm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Application of gene amplification by polymerase chain reaction to genetic analysis of molar mitochondrial DNA: The detection of anuclear empty ovum as the cause of complete mole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

The syndromes of hydatidiform mole. II. Morphologic evolution of the complete and partial mole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

The syndromes of hydatidiform mole. I. Cytogenetic and morphologic correlations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Very early complete hydatidiform mole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non-molar hydropic abortions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

The changing clinical presentation of complete molar pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Sonographic appearance of first trimester complete hydatidiform moles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Ultrasonography of partial hydatidiform mole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Prospective follow-up of patients with hydatidiform mole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

The influence of the primary treatment of hydatidiform mole on its subsequent course

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Gestational trophoblastic disease in women aged 50 or more

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

The problem of identification of prognostic factors for persistent trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Prophylactic chemotherapy for hydatidiform mole. Five to 15 years follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Effects of prophylactic chemotherapy for persistent trophoblastic disease in patients with complete hydatidiform mole.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Relationship of oral contraceptives and the intrauterine contraceptive devices to the regression of concentrations of the beta subunit of human chorionic gonadotropin and invasive complications after molar pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Intracerebral choriocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Central nervous system metastases of choriocarcinoma. 23 years' experience at Charing Cross Hospital.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Cerebral metastatic choriocarcinoma in the People's Republic of China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Liver metastases of gestational trophoblastic tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

SEQUENTIAL USE OF METHOTREXATE AND ACTINOMYCIN D IN THE TREATMENT OF METASTATIC CHORIOCARCINOMA AND RELATED TROPHOBLASTIC DISEASES IN WOMEN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Metastatic gestational trophoblastic disease: A comparison of prognostic classification systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Prognostic factors in gestational trophoblastic tumors: a proposed new scoring system based on multivariate analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

An evaluation of the prognostic factors in metastatic gestational trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Treatment and prognosis of post term choriocarcinoma in The Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

The role of operation in the current therapy of gestational trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Role of computed axial tomography of the chest in staging patients with nonmetastatic gestational trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Immunodiagnosis and monitoring of gonadotrophin-producing metastases in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Actinomycin D as the primary agent for gestational trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Single-dose actinomycin-D treatment for nonmetastatic gestational trophoblastic disease. A prospective phase II trial of the Gynecologic Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Alternating methotrexate and dactinomycin in nonmetastatic gestational trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

High-risk metastatic gestational trophoblastic disease: further stratification into two clinical entities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Cisplatin, vinblastine, and bleomycin combination therapy in resistant gestational trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Cisplatin, vinblastine, and bleomycin combination in the treatment of resistant high-risk gestational trophoblastic tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Ifosfamide alone and in combination in the treatment of refractory malignant gestational trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

High-dose chemotherapy with autologous bone marrow transplantation for refractory metastatic gestational trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Surgical indications for resection in pulmonary metastasis of choriocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Salvage surgery for chemorefractory gestational trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Gestational Trophoblastic Disease Metastatic to the Central Nervous System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Recurrent gestational trophoblastic disease. Experience of the Southeastern Regional Trophoblastic Disease Center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Subsequent reproductive experience after treatment for gestational trophoblastic disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Reproductive performance of patients with gestational trophoblastic disease in Hong Kong

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Pregnancy outcomes after successful chemotherapy for choriocarcinoma and invasive mole: long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Pregnancies after chemotherapy of trophoblastic neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Hydatidiform mole in England and Wales 1973-83.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

The psychological, social, and sexual consequences of gestational trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

The impact of molar pregnancy on psychological symptomatology, sexual function, and quality of life.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

Relationship of oral contraception to development of trophoblastic tumour after evacuation of a hydatidiform mole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

7 January 2021

Treatment of metastatic trophoblastic disease: good and poor prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

7 January 2021

The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

7 January 2021

Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.005

7 January 2021

10.1016/J.YGYNO.2008.09.005

Identifiers

DOI

1 reference

19 August 2017

1 reference